Weekly Research Analysts’ Ratings Changes for Lionsgate Studios (LION)

by · The Cerbat Gem

Several brokerages have updated their recommendations and price targets on shares of Lionsgate Studios (NYSE: LION) in the last few weeks:

  • 5/5/2026 – Lionsgate Studios had its price target raised by Robert W. Baird from $14.00 to $16.00. They now have an “outperform” rating on the stock.
  • 5/1/2026 – Lionsgate Studios had its price target raised by Morgan Stanley from $11.00 to $14.00. They now have an “overweight” rating on the stock.
  • 4/28/2026 – Lionsgate Studios had its price target raised by Barrington Research from $11.50 to $14.50. They now have an “outperform” rating on the stock.
  • 4/27/2026 – Lionsgate Studios had its price target raised by Benchmark Co. from $12.00 to $15.00. They now have a “buy” rating on the stock.
  • 4/26/2026 – Lionsgate Studios was downgraded by Wall Street Zen from “hold” to “sell”.
  • 4/21/2026 – Lionsgate Studios had its “sell (d-)” rating reaffirmed by Weiss Ratings.
  • 4/20/2026 – Lionsgate Studios was downgraded by Citigroup Inc. from “buy” to “neutral”. They now have a $12.60 price target on the stock, up from $11.00.
  • 4/18/2026 – Lionsgate Studios was upgraded by Wall Street Zen from “sell” to “hold”.
  • 4/16/2026 – Lionsgate Studios had its price target raised by Robert W. Baird from $12.00 to $14.00. They now have an “outperform” rating on the stock.
  • 3/23/2026 – Lionsgate Studios had its price target raised by Citigroup Inc. from $9.00 to $11.00. They now have a “buy” rating on the stock.

Lionsgate Studios, operating under the ticker NYSE:LION, is a leading global entertainment company specializing in the production, acquisition and distribution of motion pictures, television programming and digital content. Headquartered in Santa Monica, California, and with additional operations in Vancouver, the company develops, finances and markets feature films that span a wide range of genres—from major franchise hits like The Hunger Games and John Wick to independent and specialty titles.

Featured Stories